Diabetes technology section


Sentek Group, Inc. is developing a non-invasive diagnostic tool targeting diabetes patients that uses a patented Crystalline Colloidal Array (CCA) technology exclusively licensed from the University of Pittsburgh. While Sentek plans to exploit several applications of the technology, the company’s first commercial efforts are for the Glucoview ocular insert that will enable diabetics to continuously monitor their blood glucose levels, and unlike most competing technologies, it will not require finger stabs.

Sensors For Medicine and Science Implanted Light-Emitting Diode

Senseonics Inc (formerly Sensors for Medicine and Science or SMSI until 2012), based in Germantown, MD,  is developing a fully implantable continuous glucose monitoring system that uses fluorescence sensing technology. Their goal is to improve accuracy, ease of use and sensor life to make glucose management better.

Orsense Ltd.

OrSense Ltd. is a medical device company based in Israel. Their first product, the NBM 200MP is based on its proprietary Occlusion Spectroscopy technology. Orsense claims this technology overcomes obstacles that have plagued other companies attempting to measure glucose optically through the skin.


Subscribe to RSS - Technology